I think Tooth did a pretty good job just now challenging you on the fact they own the patents.

But even if you want to ignore that, you can't just say big pharma hopes it fails and then assume every single big pharma company falls into that category. I already named Valeant for you. Valeant is 95% products that wouldn't "conflict" with this. They've watched their market cap erode by almost 100 billion. You think in that nose dive they didn't have one guy smarter than you that would have gone to get them the cure to everything + the patents for it?

It's scary you don't see what's right in front of you. I guess unless you are indeed just pumping to save yourself.

You're not remotely worried about a company that makes claims to the rest though, while fleeing to Africa to complete? Kind of a wicked tell.

"You don't think a dying animal like VRX would say "let's toss these guys 300m for the cure to anything". "

Unfortunately, the company is not for sale yet. The thing about this stock is that it is cheap, but that doesn't mean you can buy a significant portion of the company for that cheap price. Maybe anybody could buy 5% of the company around the current market cap of $20m, but then you run into 95% of the shares that are not selling cause they know what it's worth.

Maybe VRX (or any other) will acquire IMUN after it commercializes in Africa. This is yet to be seen.

In my opinion, it would make more sense for big pharma to acquire IMUN after commercialization as I've already stated. For 1, if the board did decide to sell NOW, you have no idea what they'd ask. Maybe they're not willing to take anything less than $300m or $500m. You don't know. I don't know.

By waiting until after commercialization (and beyond really), big pharma still gets the possibility of the drug or the company failing - then, they get to pay $0 for the same exact result. Seems like the smart plan for them to hold off.

For smaller investors (looking to buy less than 5% of the company), timing means a different thing.

Again, stop calling me an idiot BEFORE you've heard my response. If you haven't noticed, SO FAR I'VE REFUTED EVERY SINGLE THING THAT HAS BEEN SAID. So let me refute before you call me an idiot. Again, remember, I'm the one who is smarter than you buddy. Everything you are typing to me was something I saw 2 years ago. So stop talking to me like you've found crazy evidence that is something new. I have an answer to everything. You're the one who looks like an idiot when you call someone an idiot, then get proven wrong.

I'm sure everybody has just briefly skimmed everything cause they don't care, but I have literally refuted EVERYTHING, and will continue to do so.

They were going to use Laboratorios Ramos. That was the plan for years. We lost 9 months because of the decision to leave Laboratorios Ramos in Nicaragua to opt for Acromax Dominicana in D.R. A whole new approval process had to initiate with D.R. which is why it added 9 more months. We're still suffering from that blow which took the stock from around .18 to where it is now (more dilution, and selloffs from panickers). More info from the 10-k...

Laboratorios Ramos in Managua, Nicaragua has been issued approval from the Minster of Health to manufacture Naltrexone for the Company under the trademark name Lodonal™. The certificate of free sale allows Naltrexone to be exported from the Managua facility to other jurisdictions where the Company is approved to market and sell Naltrexone in satisfaction of the import requirements of such jurisdictions. The free sale certificate is not a license for export, which is issued separately for a specific product in both the country of export as well as the country of import.

Due to political developments in Nicaragua in the second half of 2016, the Company decided it would be prudent to obtain a second source of LDN product supply for sales outside of North America. In October 2016, the Company and Acromax Dominicana, SA (“Acromax”) entered into a contract for the manufacture of LDN tablets, capsules and/or creams (“Agreement”). Acromax is located in Santo Domingo; in the Dominican Republic. It is both cGMP certified and ISO 9001: 2008 certified. Acromax exports over 160 products and has sold throughout the Caribbean and Central and South America. More information about Acromax is available at http://acromaxdominicana.com/ .



And in response to this...

"Um, what?? It just got approved by the "Nigerian FDA" in 2016. How the actual **** did they, in 2013, expect to sell $50 million worth the following year, and have a distribution agreement already in place, when it hadn't been approved and no trials had been done????????????

Notice again it's on the cusp of big profit...better buy now! They're building billion pill factories! They're going to make $50 million/year in 2014 in Nigeria! None of this came to pass. They didn't sell one pill anywhere in the world in 2014 that I can see.

Why do you think the changed their name? Because the idiots who type in the company name to do research would have noticed this, and known was up. Instead, they now run into flowery sounding company press releases on NASDAQ.com."

Noreen, the CEO, discussed this in detail in January in the investor conference.

Quote:
To the best of our knowledge, we are the only company that has ever advanced a non-FDA drug, or generic, through an approval process in an emerging market. This is a major accomplishment, one that bodes well for our numerous other initiatives that are similar in nature.

She further went on to talk about how because it was the first time for both NAFDAC and for IMUN and Noreen of course, there were MANY mistakes made (many will say it's NAFDAC's fault, many will say it's the CEO's fault, but nobody knows really and it won't affect the future anyway), and nobody really knew how long it was going to take in the beginning. NAFDAC misrepresented things to the company from my understanding (starting with the 1 year long delay in 2012-13 for the certificate of free sale). Because of the misrepresentations, and subsequent dilutions / panic selling / dumping, etc, the stock torched. Nobody wanted to touch it until they came close to commercialization. And now we are finally here.

Look. You either believe it or you don't. I've done more DD than any other share holder in this company. I drove to f***ing Washington DC (really really far drive) to stop in at Howard University to chat with an old advisor of IMUN to see what he thinks about the company. I search for every answer. And I get it. I ****ing stalked. And pissed off everyone in the company. And guess what - I got my DD done. And I can see exactly why the stock is about to go up. You either believe it or you don't, but so far, nobody has said anything that I haven't refuted yet.

Keep it coming.

I'm done.

I'm wasting more time on this than I should, but...THEY DON'T EVEN OWN THE PATENTS YOU LISTED

https://assignment.uspto.gov/patent/...43&type=patNum

https://assignment.uspto.gov/patent/...%20GROUP%20LLC

https://www.google.com/patents/US800...gdAtcQ6AEIJzAA

At best, they are taking licenses from the patent owners for royalty fees, and I'm sure the patent owners are more than happy to take IMUN's money. At worst, IMUN's counsel couldn't be arsed to record title to the patents you cited and blew away $98 million dollars.

Also, if they're doing trials in Africa, why do they not have any African patents? Patents are only good for the country where they are obtained. Why no Nigerian patents? If they don't have them, then any fly-by-night manufacturer can set up a generic plant to compete with them once trials are completed, and there would be **** all IMUN could do about it.

I've put the links for the patents in one of the last few posts. And I mentioned my opinion on why a buyout would be better for both sides to be AFTER commecialization.

-big pharma has its hopes of the company / drug failing (hence paying $0 for what they want), plus the fact that 95% of shares aren't selling at a low price
-the company knows it will get a much higher valuation selling after hitting commercialization

Keep em coming.

Mori.

Stop it

They do own the patents. What???? Then who owns them, so I can refute. Read the 10-k before you make such a ridiculous claim. This is a fully reporting company in case you want to go any further. They acquired them when Dr. Bihari passed away.

The patents are INTERNATIONAL, from the 10-k...

The Company, either directly or through its collaborating partners, is working with drug regulatory authorities in Nicaragua, China and in those African Nations where an FDA equivalent exists. The Company is working with the agencies to obtain local approval for the therapies for each modality that we intend to market for. We believe this will reduce our risk due to The Agreement on Trade Related Aspects of Intellectual Property Rights (“TRIPS”) which is an international agreement administered by the World Trade Organization (“WTO”). TRIPS allows emerging nations to manufacture drugs around existing patents.

So basically, it's a 10 bagger minimum IMO. Anything else I haven't refuted yet?

DISCLAIMER: NONE OF THIS WAS INVESTMENT ADVICE!

Well that's certainly amusing. Cognitive dissonance at full gallop.

You didn't answer my question, you slimily avoided it while claiming to have answered everything. So here it is again:

In 2012, IMUN / TNI claimed in a press release that they were currently building a billion pill a year factory, to be finished soon and begin export to Africa the next year. Did this factory get built? Yes or no.
Everyone except you realizes that this is over.

The facts we have so far:

- Their drug is a low dose opioid antagonist which is claimed to be effective in treating 50+ diverse diseases, from MS to breast cancer to Alzheimer's to HIV
- They claimed in 2012 that they were building a billion pill/year factory. This factory doesn't exist. You refuse to even answer questions about that.
- Their office, and those of their subsidiary companies, is virtual office space in Florida that they rent for $65/month
- They claimed in a 2013 press release that they had a distribution agreement in place in Nigeria, and that export would start soon, and that they were expecting $50 million/year in 2014. Despite having no approvals, and no studies at the time in Nigeria. This is how that turned out:

Company prediction: $50 million/year sales in Nigeria in 2014.
Reality:


Shall I go through more TNI press releases and make you look worse and worse, or are you done being and acting the fool? This is a transparent pump, and you're transparently an idiot.

This is as funny as the Ackman call two years ago where he takes on every question to defend Valeant. It's over. Move on. At this point you're just making it worse for yourself.

Now I have a question for this board:

Why did you all keep TELLING me I was wrong, INSTEAD of ASKING me questions about the company to see if I had answers? Look at yourselves in the mirror IMO.

It turns out I refuted every single statement when someone told me I was wrong.

If I didn't, I must have missed it. Please restate.

Your Dr.'s patents were acquired by Ms. Jacqueline Young for the princely sum of One ($1) US Dollar:

http://legacy-assignments.uspto.gov/...-28989-838.pdf

The other ones are owned by UPenn and other entities, which is evident from just LOOKING UP THE PATENT NUMBERS.

There is no such thing. Each country has its own patent office. Patents are very specific for only the country obtained.

There is an international patent application called the PCT application, but that is used as a placeholder to file into countries directly after 30 months, and does not function as a patent.


Your section there refers to countries having the right to refuse to grant patent rights for certain pharmaceutical patents, and/or seize such patents in the interest of public health:

https://www.wto.org/english/tratop_e..._pharm02_e.htm

Meaning that they are relying on the Nigeria government and other African nations to kill all patent rights related to your wonder drug so that they can manufacture freely. If that's what they are relying on, then we go back to my original question; what stops other fly-by-night manufacturers from ripping IMUN off?

What other bridges do you have for sale?

Marathon man, you're truly living in some alternate universe if you've somehow convinced yourself that you are in this thread refuting arguments and coming across intelligent. It's become pretty clear that the reason your cousin and his friend likely decided to bring this topic to a random forum full of strangers is because you're off the deep end and they probably want you to hear it from strangers that have no vested interest one way or the other.

This forum is filled with a lot of very knowledgeable and experienced traders. The kiddie game is over at investorhub or whichever forum it is that allowed you to become a mod. Please can you post a single thing where you've proven someone wrong? You keep talking about refuting arguments but your explanations are all terribly shallow, irrational, illogical, and reek of desperation. You're getting tossed around left, right, and center in this thread, but the fact that you can't see that is making for a bit of an entertaining circus act.

Well, if this thread is any representation of all this "DD" you've done then it's fair to say you've been wasting your time and money. You've somehow created a reality for yourself in which you are this genius, enlightened, all-knowing guru for a PnD penny stock -- despite the reality being that you are out of your league, no clue about biotech, and pot committed both emotionally/financially to the point where you can no longer accept the truth.

But, to keep this s**t show going, you claim you've answered everything, but these seem to be some questions posed to you that you haven't answered (perhaps you can copy/paste the answer if I've somehow missed it in your ramblings):

Everyone except you realizes that this is over.

The facts we have so far:

- Their drug is a low dose opioid antagonist which is claimed to be effective in treating 50+ diverse diseases, from MS to breast cancer to Alzheimer's to HIV

Yes, that is correct. Here is a forum where 1000's of people who have been helped by LDN post their success stories.

http://ldn.proboards.com/

And a book which I've already posted. Go and read it.

https://www.amazon.com/Promise-Low-D...ose+naltrexone

- They claimed in 2012 that they were building a billion pill/year factory. This factory doesn't exist. You refuse to even answer questions about that.

I will talk about this in my next post...

- Their office, and those of their subsidiary companies, is virtual office space in Florida that they rent for $65/month.

Yes, I've responded to this. With 5 employees, everybody able to work from their own location, and everybody traveling, why pay for rent when it is literally not needed?

- They claimed in a 2013 press release that they had a distribution agreement in place in Nigeria, and that export would start soon, and that they were expecting $50 million/year in 2014. Despite having no approvals, and no studies at the time in Nigeria. This is how that turned out:

I will talk about this in next post...

Oh my god just let it end please

Quote:
The one in Nigeria isn't even blinded, which means that no one is going to take it seriously. Why was it not blinded??? It doesn't cost anything to blind a study.

I don't know why it wasn't blinded. I guess you make a good point.

Quote:
So TNI - now name changed to IMUN for some reason - according to their own company statements, was supposed to be starting Phase III clinical trials in the next year, 5 years ago. Note the big deal, the "around the corner' language that hints you should get in now because it's too late. Such is the nature of penny scammers. Low intelligence chumps (who think they have high IQs) bought up. What happened to their money?

Again, I will answer this in next post (as I stated in last post)

Quote:
Tell me how the Nigerian thing is better than the event above, on the cusp of PHASE III American trials in the next year after scoring a huge patent portfolio.

-The Nigerian thing is better than American trials because the market is untapped.
-Zero competition
-Easier to get approved in
-Getting approved in Africa first will make it easier to get approved for Phase 3 trials in US (as the FDA is influenced by big pharma, and big pharma will lose money if the drug gets in to US)

This is especially hilarious considering the Toothsayer post directly above it with a great summation of how this thread has gone. Enjoy that kool-aid though.

Mod should just segregate it to another thread. The entertainment value here though

I know the friend of the cousin who posted the original query about IMUN. I can confirm that MarathonMan is definitely not here to pump the stock.

I also know that Extremely High Dose Naltrexone (EHDN) has passed Phase VII trials in Mongolia for treatment of True-Believer Syndrome. An LD50 dose was proved to eradicate the syndrome in approximately 50% of all human trials.

Confirmed wonder drug.

OK, sorry for the delay in posting my last post in the few things I hadn't refuted, all related to previous publications from 2012-2014 from TNI Biotech (billion dollar plant not getting build, etc, and other things of this nature)

I do have what I BELIEVE to be the exact answer that will refute all such inquiries. I am not going to answer it though, I'm sorry. It is my speculation, and I have invested a **** load of money based on this speculation (actually I hadn't come to the realization until I already invested because when I first invested, I hadn't done my full DD). Then I realized what I believe to be the answer to your question after already being invested, and did continue to invest a **** ton more. So I stuck with it, cause I realized IMUN is gold IN MY OPINION.

Go figure it out for YOURSELF - the answer to your questions. There is certainly an answer imo.

Imun is going straight up from here in my opinion.

Disclaimer: this is not investment advice.

And yes, I will admit that I don't know why the bridging trial wasn't blinded. However, I can see how IMUN wouldn't want it blinded anyway. Maybe you don't think that's the best course of action, but I think there are arguments for both sides.

Go on Proboards to read about LDN. I posted a link in here somewhere. Confirmed wonder drug is right. You'll hear another 1000 people say it on Proboards.

This has to be a troll and got everyone amped up. Clearly there isn't any one this clueless... or is there?

Well, I do believe that's a fitting end.

We now return you to your regular programming.
I think 2p2 has spoiled you. You should go frequent some other stock message boards. Pure amped up crazy on every penny that exists. At the very least, worth reading for an insight into investor psychology. There's a whole multi billion dollar industry set up around fleecing these true believers and getting them whipped up so they spread the word.